Investigating how enteral nutrition affects sepsis progression
Effects of Enteral Nutrition Content on Disease Progression in Sepsis Patients
This study is testing how different types of enteral nutrition affect the health of patients with sepsis in the intensive care unit.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Inonu University Academic / other |
| Locations | 1 site (Sanliurfa) |
| Trial ID | NCT06943326 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the impact of enteral nutrition content on the progression of sepsis in patients receiving treatment in an intensive care unit. Sepsis is a critical condition characterized by an overactive inflammatory response, and effective management is crucial for patient outcomes. The study will assess how different macro- and micronutrient compositions in enteral nutrition can influence inflammatory and immune responses, potentially affecting disease outcomes. Conducted at Mehmet Akif Inan Training and Research Hospital, the study will involve monitoring the nutritional intake of sepsis patients to evaluate its effects on their health status.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with sepsis who can receive enteral nutrition within 24 hours of treatment initiation.
Not a fit: Patients with chronic liver disease, chronic renal failure, active cancer, or those receiving parenteral nutrition may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved nutritional strategies that enhance recovery and outcomes for sepsis patients.
How similar studies have performed: Existing literature suggests that different enteral nutrient compositions can significantly affect sepsis outcomes, indicating that this approach has been explored with some success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being diagnosed with sepsis and being able to receive enteral nutrition 24 hours after starting treatment in the intensive care unit Exclusion Criteria: * chronic liver disease, chronic renal failure, active cancer or parenteral nutrition
Where this trial is running
Sanliurfa
- Mehmet Akif Inan Training and Research Hospital — Sanliurfa, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Hakan Toğuç
- Email: hakan.toguc@inonu.edu.tr
- Phone: +905073625100
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.